Association of Electronic Cigarette Use With Subsequent Initiation of Tobacco Cigarettes in US Youths.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 02 2019
Historique:
entrez: 2 2 2019
pubmed: 2 2 2019
medline: 4 12 2019
Statut: epublish

Résumé

The use of electronic cigarettes (e-cigarettes) and other noncigarette tobacco products may increase the odds of cigarette initiation, even among low-risk youths. To evaluate the associations of prior e-cigarette use and other tobacco product use with subsequent cigarette initiation within 2 years of follow-up. In this prospective cohort study, data from waves 1 through 3 of the Population Assessment of Tobacco and Health Study (2013-2016) were used to assess youths aged 12 to 15 years who had never used cigarettes, e-cigarettes, or other tobacco products at wave 1. This was a nationally representative study of the US population. Data analysis was conducted in 2018. First noncigarette tobacco product used (none, e-cigarette, or other tobacco product) between wave 1 and wave 3. Ever cigarette use and current cigarette use at wave 3. In the sample (N = 6123), respondents were 49.5% female; 54.1% non-Hispanic, white; and the mean (SD) age was 13.4 (1.2) years. Of these, 8.6% reported e-cigarettes as their first tobacco product, while 5.0% reported using another noncigarette product first; 3.3% reported using cigarettes first. Cigarette use at wave 3 was higher among prior e-cigarette users (20.5%) compared with youths with no prior tobacco use (3.8%). Prior e-cigarette use was associated with more than 4 times the odds of ever cigarette use (odds ratio, 4.09; 95% CI, 2.97-5.63) and nearly 3 times the odds of current cigarette use (odds ratio, 2.75; 95% CI, 1.60-4.73) compared with no prior tobacco use. Prior use of other tobacco products was similarly associated with subsequent ever cigarette use (OR, 3.84; 95% CI, 2.63-5.63) and current cigarette use (OR, 3.43; 95% CI, 1.88-6.26) compared with no prior tobacco use. The association of prior e-cigarette use with cigarette initiation was stronger among low-risk youths (OR, 8.57; 95% CI, 3.87-18.97), a pattern not seen for prior other product use. Over the 2 years between 2013 and 2014 and 2015 and 2016, 21.8% of new cigarette ever use (178 850 youths) and 15.3% of current cigarette use (43 446 youths) among US youths aged 12 to 15 years may be attributable to prior e-cigarette use. This study's findings support the notion that e-cigarette use is associated with increased risk for cigarette initiation and use, particularly among low-risk youths. At the population level, the use of e-cigarettes may be a contributor to the initiation of cigarette smoking among youths.

Identifiants

pubmed: 30707232
pii: 2723425
doi: 10.1001/jamanetworkopen.2018.7794
pmc: PMC6484602
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e187794

Subventions

Organisme : NHLBI NIH HHS
ID : P50 HL120163
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL120163
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA180905
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA180905
Pays : United States

Références

JAMA Pediatr. 2017 Aug 1;171(8):788-797
pubmed: 28654986
Am J Public Health. 1998 Jan;88(1):15-9
pubmed: 9584027
JAMA. 2015 Aug 18;314(7):700-7
pubmed: 26284721
Tob Control. 2017 Jul;26(4):371-378
pubmed: 27507901
Nicotine Tob Res. 2007 Dec;9(12):1331-7
pubmed: 18058351
Addiction. 2018 Oct;113(10):1776-1783
pubmed: 28786147
Am J Prev Med. 2014 Oct;47(4):505-7
pubmed: 25092121
Drug Alcohol Depend. 2003 Dec 11;72(3):279-86
pubmed: 14643945
JAMA Pediatr. 2018 Feb 1;172(2):181-187
pubmed: 29297010
Tob Control. 2017 Jan;26(1):34-39
pubmed: 26811353
Pediatrics. 2017 Jun;139(6):
pubmed: 28562266
Addict Behav. 2018 Jan;76:343-347
pubmed: 28892771
Tob Control. 2016 Sep;26(5):534-539
pubmed: 27543564
Tob Regul Sci. 2016 Jul;2(3):290-293
pubmed: 29423429
Nicotine Tob Res. 2019 Jan 1;21(1):41-47
pubmed: 29617887
Tob Control. 2017 Aug 17;:
pubmed: 28818839
Drug Alcohol Depend. 2017 May 1;174:209-214
pubmed: 29350617
J Adolesc Health. 2013 Feb;52(2):144-50
pubmed: 23332477
Tob Control. 2017 Jul 22;:
pubmed: 28735273
Am J Prev Med. 2017 Feb;52(2):e33-e66
pubmed: 27914771
Nicotine Tob Res. 2015 Jul;17(7):847-54
pubmed: 25481917
Nicotine Tob Res. 2016 May;18(5):647-53
pubmed: 26386472
MMWR Morb Mortal Wkly Rep. 2017 Jan 20;66(2):47-50
pubmed: 28103214
Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9
pubmed: 21499542
Int J Tuberc Lung Dis. 2015 Apr;19(4):481-7
pubmed: 25860006
Pediatrics. 2015 Jan;135(1):e43-51
pubmed: 25511118
BMJ. 2018 Feb 22;360:k757
pubmed: 29472187
CMAJ. 2017 Oct 30;189(43):E1328-E1336
pubmed: 29084759
Tob Control. 2019 Nov;28(6):629-635
pubmed: 30459182
Tob Control. 2017 Dec;26(e2):e106-e111
pubmed: 28167683
Pediatrics. 2016 Jul;138(1):
pubmed: 27296866
MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277
pubmed: 30439875
N Engl J Med. 2011 Jul 21;365(3):193-5
pubmed: 21774706
JAMA Pediatr. 2015 Feb;169(2):129-36
pubmed: 25485959
Drug Alcohol Depend. 2017 Nov 1;180:427-430
pubmed: 28988005
Addict Behav. 2017 Apr;67:66-72
pubmed: 28038364
JAMA. 1998 Nov 18;280(19):1690-1
pubmed: 9832001
N Engl J Med. 2014 Jan 23;370(4):293-5
pubmed: 24350902
Nicotine Tob Res. 2003 Aug;5(4):561-9
pubmed: 12959794

Auteurs

Kaitlyn M Berry (KM)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts.

Jessica L Fetterman (JL)

Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.

Emelia J Benjamin (EJ)

Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.

Aruni Bhatnagar (A)

Department of Medicine, University of Louisville, Louisville, Kentucky.

Jessica L Barrington-Trimis (JL)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.

Adam M Leventhal (AM)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.

Andrew Stokes (A)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH